Intangibles (Schedule of JMC Recognized Expense Related to its Product Licenses) (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Finite-Lived Intangible Assets [Line Items] | ||
Beginning balance | $ 14,629 | |
Ending balance | 12,552 | $ 14,629 |
Accutane [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Ending balance | 3,939 | |
Anti-itch Product [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Amortization expense | 0 | |
Journey [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Beginning balance | 14,629 | 7,377 |
Amortization expense | (2,474) | (1,420) |
Ending balance | 12,552 | 14,629 |
Journey [Member] | Accutane [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Additions | 4,727 | |
Journey [Member] | Anti-itch Product [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Additions | $ 3,945 | |
Journey [Member] | Exelderm [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Additions | $ 397 |
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|